Understand the source comparison
Adamax FAQ: Research Application Comparison
Research applications for Adamax span metabolic studies, pigmentation research, and appetite regulation models. The comparison below shows how Adamax differs from related compounds in mechanism, administration, and typical research contexts. Adamax (Melanotan
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research applications for Adamax span metabolic studies, pigmentation research, and appetite regulation models. The comparison below shows how Adamax differs from related compounds in mechanism, administration, and typical research contexts.
- Adamax (Melanotan II)
- MC1R, MC3R, MC4R, MC5R (non-selective)
- 2–3 hours
- Daily to 3×/week
- Appetite regulation, energy expenditure, pigmentation
- Broadest melanocortin activity; requires precise dosing due to narrow therapeutic window
- PT-141 Bremelanotide
- MC3R, MC4R (selective)
- 2.7 hours
- As needed
- Sexual function, arousal pathways
- Selective MC4R agonist without significant MC1R activation (minimal pigmentation)
- Melanotan 1
- MC1R (highly selective)
- 30–60 minutes
- Daily
- Dermatological research, photoprotection
- Strong MC1R affinity with minimal central MC4R effects; shorter half-life requires more frequent dosing
- Tesofensine
- Triple monoamine reuptake inhibitor
- 8 days
- Once daily
- Appetite suppression, thermogenesis
- Completely different mechanism (norepinephrine/dopamine/serotonin reuptake); longer half-life simplifies protocol
- AOD9604
- Growth hormone receptor (lipolytic fragment)
- 30 minutes
- Fat oxidation without GH side effects
- Selective lipolysis without melanocortin pathway; no pigmentation or appetite effects
- The table clarifies that while Adamax, PT-141, and Melanotan 1 share melanocortin receptor activity, their receptor selectivity profiles produce entirely different research applications. Adamax is the broadest tool. Useful when studying multiple melanocortin pathways simultaneously, but requiring more careful dose titration than receptor-selective analogs.